Single-Domain Antibodies Targeting Neuraminidase Protect against an H5N1 Influenza Virus Challenge
出版年份 2014 全文链接
标题
Single-Domain Antibodies Targeting Neuraminidase Protect against an H5N1 Influenza Virus Challenge
作者
关键词
-
出版物
JOURNAL OF VIROLOGY
Volume 88, Issue 15, Pages 8278-8296
出版商
American Society for Microbiology
发表日期
2014-05-15
DOI
10.1128/jvi.03178-13
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A Systems Analysis Identifies a Feedforward Inflammatory Circuit Leading to Lethal Influenza Infection
- (2013) Marlène Brandes et al. CELL
- The Universal Epitope of Influenza A Viral Neuraminidase Fundamentally Contributes to Enzyme Activity and Viral Replication
- (2013) Tracey M. Doyle et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Molecular Basis for Broad Neuraminidase Immunity: Conserved Epitopes in Seasonal and Pandemic H1N1 as Well as H5N1 Influenza Viruses
- (2013) H. Wan et al. JOURNAL OF VIROLOGY
- Clinical Findings in 111 Cases of Influenza A (H7N9) Virus Infection
- (2013) Hai-Nv Gao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fusion of an Fc chain to a VHH boosts the accumulation levels inArabidopsisseeds
- (2013) Sylvie De Buck et al. PLANT BIOTECHNOLOGY JOURNAL
- Generation of VHH antibodies against the Arabidopsis thaliana seed storage proteins
- (2013) Thomas De Meyer et al. PLANT MOLECULAR BIOLOGY
- Formatted single-domain antibodies can protect mice against infection with influenza virus (H5N2)
- (2012) Sergei V. Tillib et al. ANTIVIRAL RESEARCH
- Decreased Neuraminidase Activity Is Important for the Adaptation of H5N1 Influenza Virus to Human Airway Epithelium
- (2012) N. A. Ilyushina et al. JOURNAL OF VIROLOGY
- Natural and long-lasting cellular immune responses against influenza in the M2e-immune host
- (2012) M Schotsaert et al. Mucosal Immunology
- Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets
- (2012) Masaki Imai et al. NATURE
- Contribution of antibody production against neuraminidase to the protection afforded by influenza vaccines
- (2012) Glendie Marcelin et al. REVIEWS IN MEDICAL VIROLOGY
- Airborne Transmission of Influenza A/H5N1 Virus Between Ferrets
- (2012) S. Herfst et al. SCIENCE
- Nanobodies®: New ammunition to battle viruses
- (2011) Peter Vanlandschoot et al. ANTIVIRAL RESEARCH
- An influenza N1 neuraminidase-specific monoclonal antibody with broad neuraminidase inhibition activity against H5N1 HPAI viruses
- (2011) Yoko Shoji et al. Human vaccines & immunotherapeutics
- Continued evolution of highly pathogenic avian influenza A (H5N1): updated nomenclature
- (2011) Influenza and Other Respiratory Viruses
- Influenza neuraminidase
- (2011) Gillian M. Air Influenza and Other Respiratory Viruses
- Nanobodies® Specific for Respiratory Syncytial Virus Fusion Protein Protect Against Infection by Inhibition of Fusion
- (2011) Bert Schepens et al. JOURNAL OF INFECTIOUS DISEASES
- Nanobodies With In Vitro Neutralizing Activity Protect Mice Against H5N1 Influenza Virus Infection
- (2011) Lorena Itatí Ibañez et al. JOURNAL OF INFECTIOUS DISEASES
- Structure of a nanobody-stabilized active state of the β2 adrenoceptor
- (2011) Søren G. F. Rasmussen et al. NATURE
- Influenza A Virus Hemagglutinin Antibody Escape Promotes Neuraminidase Antigenic Variation and Drug Resistance
- (2011) Scott E. Hensley et al. PLoS One
- Llama-Derived Single Domain Antibodies to Build Multivalent, Superpotent and Broadened Neutralizing Anti-Viral Molecules
- (2011) Anna Hultberg et al. PLoS One
- Potent Neutralization of Influenza A Virus by a Single-Domain Antibody Blocking M2 Ion Channel Protein
- (2011) Guowei Wei et al. PLoS One
- Production of antibodies in plants: status after twenty years
- (2010) Benoit De Muynck et al. PLANT BIOTECHNOLOGY JOURNAL
- Qualitative and quantitative analyses of virtually all subtypes of influenza A and B viral neuraminidases using antibodies targeting the universally conserved sequences
- (2010) Caroline Gravel et al. VACCINE
- Pandemic preparedness: Toward a universal influenza vaccine
- (2009) K. Roose et al. DRUG NEWS & PERSPECTIVES
- Protective Immunity Afforded by Inactivated H5N1 (NIBRG‐14) Vaccine Requires Antibodies against Both Hemagglutinin and Neuraminidase in Mice
- (2009) Yoshimasa Takahashi et al. JOURNAL OF INFECTIOUS DISEASES
- Neuraminidase Stalk Length and Additional Glycosylation of the Hemagglutinin Influence the Virulence of Influenza H5N1 Viruses for Mice
- (2009) Y. Matsuoka et al. JOURNAL OF VIROLOGY
- Geographic Dependence, Surveillance, and Origins of the 2009 Influenza A (H1N1) Virus
- (2009) Vladimir Trifonov et al. NEW ENGLAND JOURNAL OF MEDICINE
- MDCK cells that express proteases TMPRSS2 and HAT provide a cell system to propagate influenza viruses in the absence of trypsin and to study cleavage of HA and its inhibition
- (2009) Eva Böttcher et al. VACCINE
- A practical influenza neutralization assay to simultaneously quantify hemagglutinin and neuraminidase-inhibiting antibody responses
- (2009) Arash Hassantoufighi et al. VACCINE
- A high dosage influenza vaccine induced significantly more neuraminidase antibody than standard vaccine among elderly subjects
- (2009) Thomas R. Cate et al. VACCINE
- Head-to-tail fusions of camelid antibodies can be expressed in planta and bind in rumen fluid
- (2008) Somrutai Winichayakul et al. BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY
- Single-domain antibodies as building blocks for novel therapeutics
- (2008) D SAERENS et al. CURRENT OPINION IN PHARMACOLOGY
- An Influenza A Vaccine Based on Tetrameric Ectodomain of Matrix Protein 2
- (2008) Marina De Filette et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Influenza A Virus Neuraminidase Limits Viral Superinfection
- (2008) I-C. Huang et al. JOURNAL OF VIROLOGY
- Rapid and reliable universal cloning of influenza A virus genes by target-primed plasmid amplification
- (2008) J. Stech et al. NUCLEIC ACIDS RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started